Catalyst Event
Medtronic PLC (MDT) · Other
From Akros U.S. Tech 100 Index (AUT100)
3/23/2026, 12:00:00 AM
Received FDA approval for an expanded indication for its OmniaSecure defibrillation lead, allowing its use for conduction system pacing.
Korean Translation
OmniaSecure 제세동 리드에 대한 전도 시스템 심박조율 사용을 허용하는 FDA의 확대 적응증 승인을 받음.
Related Recent Events
Adobe Inc (ADBE) · Earnings Release
Adobe's Q2 2026 earnings release is scheduled for June 12, 2026, which is expected to have a high market impact (>=10%) as it provides the next official update on financial performance scheduled.
6/12/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA decision on LEQEMBI IQLIK (subcutaneous) for treatment initiation is scheduled. The FDA granted Priority Review for this supplemental Biologics License Application, with a PDUFA action date of May 24, 2026, which is expected. This event is expected to have a high price impact due to the significant market potential of the new delivery method.
5/24/2026, 12:00:00 AM
Medtronic PLC (MDT) · Earnings Release
Q4 and full-year fiscal 2026 earnings release scheduled.
5/20/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
The next quarterly earnings release on 2026-05-14 is scheduled.
5/14/2026, 12:00:00 AM
Roblox Corp (RBLX) · Earnings Release
Roblox's Q1 2026 earnings report is scheduled. Earnings releases typically cause significant price movement, but the immediate impact of the scheduling itself is estimated to be Low.
5/7/2026, 12:00:00 AM
Rockwell Automation Inc. (ROK) · Earnings Release
Medium importance is assigned as earnings releases typically result in significant price volatility; Q2 2026 earnings release is scheduled; analysts forecast EPS of approximately $2.88 estimated.
5/5/2026, 12:00:00 AM